These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12486126)

  • 1. Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells.
    Assaraf YG; Rothem L; Hooijberg JH; Stark M; Ifergan I; Kathmann I; Dijkmans BA; Peters GJ; Jansen G
    J Biol Chem; 2003 Feb; 278(9):6680-6. PubMed ID: 12486126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate.
    Stark M; Rothem L; Jansen G; Scheffer GL; Goldman ID; Assaraf YG
    Mol Pharmacol; 2003 Aug; 64(2):220-7. PubMed ID: 12869626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
    J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
    J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
    Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
    J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
    Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
    Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
    Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
    Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
    Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
    J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
    Hooijberg JH; Jansen G; Assaraf YG; Kathmann I; Pieters R; Laan AC; Veerman AJ; Kaspers GJ; Peters GJ
    Biochem Pharmacol; 2004 Apr; 67(8):1541-8. PubMed ID: 15041471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line.
    Dixon KH; Trepel JB; Eng SC; Cowan KH
    Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.
    Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH
    J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1).
    Hooijberg JH; Jansen G; Kathmann I; Pieters R; Laan AC; van Zantwijk I; Kaspers GJ; Peters GJ
    Cancer Chemother Pharmacol; 2014 May; 73(5):911-7. PubMed ID: 24595806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.
    Zhao R; Gao F; Hanscom M; Goldman ID
    Clin Cancer Res; 2004 Jan; 10(2):718-27. PubMed ID: 14760095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells.
    Assaraf YG; Goldman ID
    J Biol Chem; 1997 Jul; 272(28):17460-6. PubMed ID: 9211890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.
    Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD
    Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.